Despite these limitations, our findings support the potential role of CSF IL-10 as an adjunct diagnostic biomarker for PCNSL, especially when biopsy is delayed, contraindicated, or yields inconclusive results. Here, IL10 is linked to primary central nervous system lymphoma.